logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. National Cancer Center Hospital East

+81471331111
Source: Site record.
http://www.ncc.go.jp/jp/ncce/index.html

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Business Status

Source: Google. OPEN

Business Category

Source: Google. General hospital

Business Subcategory

Source: Google. General hospital
Source: Trial-derived.
447Total Trials
Source: Trial-derived.
114Recruiting Trials
Source: Trial-derived.
268Active Trials
Source: Trial-derived.
126Completed Trials
Source: Trial-derived.
423Unique Conditions
Source: Trial-derived.
130Unique Sponsors

Conditions

Source: Trial-derived. Advanced Solid Tumors (20)Source: Trial-derived. Carcinoma, Non-Small-Cell Lung (17)Source: Trial-derived. Non-small Cell Lung Cancer (16)Source: Trial-derived. Non-Small Cell Lung Cancer (15)Source: Trial-derived. Advanced Solid Tumor (14)Source: Trial-derived. Gastric Cancer (14)Source: Trial-derived. Solid Tumors (14)Source: Trial-derived. Colorectal Cancer (13)

Sponsors

Source: Trial-derived. Merck Sharp & Dohme LLC (99)Source: Trial-derived. AbbVie (46)Source: Trial-derived. Pfizer (39)Source: Trial-derived. Amgen (38)Source: Trial-derived. Daiichi Sankyo (28)Source: Trial-derived. Eli Lilly and Company (25)Source: Trial-derived. Janssen Research & Development, LLC (17)Source: Trial-derived. Ono Pharmaceutical Co., Ltd. (17)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture
Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. CT Scan
Source: AI-inferred. MRI
Source: AI-inferred. SPECT / nuclear medicine
Source: AI-inferred. PET-CT
Source: AI-inferred. Echocardiography
Source: AI-inferred. DEXA Scan

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Histology / pathology
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Sequencing / genomics

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Bone marrow biopsy
Source: AI-inferred. Intensity-modulated radiation therapy
Source: AI-inferred. Apheresis
Source: AI-inferred. Endoscopy / colonoscopy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. Minimal residual disease (MRD) testing
Source: AI-inferred. PD-L1 expression testing
Source: AI-inferred. EGFR mutation and ALK rearrangement testing
Source: AI-inferred. Left ventricular ejection fraction measurement
Source: AI-inferred. Ophthalmologic examination
Source: AI-inferred. PD-L1 immunohistochemistry (CPS) testing
Source: AI-inferred. Radiographic tumour response assessment